Skip to content
Dx

ICD-10-CM 2027 diagnosis code

D01.5Carcinoma in situ of liver, gallbladder and bile ducts

✓ Billable / specific

D01.5 is a valid, billable ICD-10-CM code for carcinoma in situ of liver, gallbladder and bile ducts. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About D01.5

D01.5 is the ICD-10-CM diagnosis code for carcinoma in situ of liver, gallbladder and bile ducts. It belongs to category D01 (carcinoma in situ of other and unspecified digestive organs), block D00-D09 (in situ neoplasms) and chapter 2 (neoplasms). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within D01 (carcinoma in situ of other and unspecified digestive organs), D01.5 is specifically for carcinoma in situ of liver, gallbladder and bile ducts. Related codes cover colon (D01.0), rectosigmoid junction (D01.1), rectum (D01.2), anus and anal canal (D01.3), other and unspecified parts of intestine (D01.4), other specified digestive organs (D01.7) and digestive organ, unspecified (D01.9).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 435 (Malignancy of Hepatobiliary System or Pancreas with MCC, relative weight 1.843), DRG 436 (Malignancy of Hepatobiliary System or Pancreas with CC, relative weight 1.1224) and DRG 437 (Malignancy of Hepatobiliary System or Pancreas without CC/MCC, relative weight 0.8081), in MDC 07 (Diseases and Disorders of the Hepatobiliary System and Pancreas), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 230.8 (carcinoma in situ of liver and biliary system).

Coding notes

Applicable toConditions and synonyms classified to this code
  • Carcinoma in situ of ampulla of Vater

Notes that apply from higher levels

Instructions written at a parent level also apply to D01.5.

› From D01 Carcinoma in situ of other and unspecified digestive organs
Excludes1
  • melanoma in situ (D03.-)

Broader instructions also apply from D00-D09 In situ neoplasms and Chapter 2: Neoplasms.

Table of Drugs & Neoplasms entries

Codes whose notes reference D01.5

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

ICD-9-CM equivalent

Converter →
  • 230.8Carcinoma in situ of liver and biliary systemexact

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about D01.5

Is D01.5 billable?

Yes. D01.5 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can D01.5 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict D01.5 as a principal diagnosis.

Is D01.5 a CC or MCC?

No. D01.5 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does D01.5 group to?

D01.5 is used in the MS-DRG v44.0 logic for MS-DRG 435 (Malignancy of Hepatobiliary System or Pancreas with MCC), MS-DRG 436 (Malignancy of Hepatobiliary System or Pancreas with CC) and MS-DRG 437 (Malignancy of Hepatobiliary System or Pancreas without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for D01.5?

The CMS General Equivalence Mappings map D01.5 to ICD-9-CM 230.8.